► Click here to download the full text file (PDF).
In response to government initiatives and targets to decrease waiting times whilst increasing the provision of patient centred care, services for improved patient driven point of care testing will undoubtedly continue to expand. This has also led to greater demand and interest for the ABX Pentra 60C+ where 5-part diff is required - eg Oncology clinics and A&E - as laboratory quality results are provided in a POCT setting, and importantly within 60 seconds.
This Case Study discusses how the ABX Pentra 60C+ has enhanced the quality of patient care and well-being as part of an integrated point of care service.
Do you have any questions or requests? Use this form to contact our specialists.